Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by G. Provazza
P1.04-28 Baseline Markers of Inflammation and Outcome With Nivolumab in Pretreated Non Small Cell Lung Cancers: A Retrospective Study
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Related publications
P1.04-29 Second or Third Line Nivolumab Versus First Line Nivolumab in Patients With Previously Treated Advanced Non Small Cell Lung Cancer (NSCLC)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Real-World Effectiveness and Safety of Nivolumab in Patients With Non-Small Cell Lung Cancer: A Multicenter Retrospective Observational Study in Japan
Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
Nivolumab in Metastatic Non–Small Cell Lung Cancer
Journal of the Advanced Practitioner in Oncology
Erlotinib Treatment in Pretreated Patients With Non-Small Cell Lung Cancer: A Phase II Study
Oncology Letters
Cancer Research
Oncology
P1.04-15 Computerized Tomography Texture Analysis as Biomarker of Benefit From Nivolumab in Advanced Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Serum GRP78 as a Tumor Marker and Its Prognostic Significance in Non-Small Cell Lung Cancers: A Retrospective Study
Disease Markers
Biochemistry
Medicine
Clinical Biochemistry
Molecular Biology
Genetics
P1.04-03 Suppressive Immune Cell Profiling in Patients With Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P1.04-33 Retrospective Descriptive Analysis of Metformin With Atezolizumab in Advanced Non-Small Cell Lung Cancer in the OAK Trial
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Clinical Factors Associated With Early Progression and Grade 3–4 Toxicity in Patients With Advanced Non-Small-Cell Lung Cancers Treated With Nivolumab
PLoS ONE
Multidisciplinary
